The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease

Rebecca Perry, Ranjit Shah, Madiha Saiedi, Sanjana Patil, Anand Ganesan, Ales Linhart, Joseph B. Selvanayagam

Research output: Contribution to journalReview articlepeer-review

42 Citations (Scopus)


Anderson-Fabry disease (AFD) is a rare X-linked inherited metabolic disorder which results in a deficiency or absence of the enzyme α-galactosidase A, leading to the accumulation of glycosphingolipids in various cells and organs including the heart. Cardiac involvement is common and results in increased myocardial inflammation, left ventricular hypertrophy (LVH), and myocardial fibrosis. Echocardiography and cardiovascular magnetic resonance (CMR) offer distinctive and often complementary use to assist in the diagnosis and monitoring pharmacologic therapy in AFD, including detection of the AFD cardiac phenotype, differentiation from other forms of LVH, and patient selection for therapeutic intervention. Advanced cardiac imaging holds promise in subclinical detection of AFD-related abnormalities as well as disease staging and prognostication.

Original languageEnglish
Pages (from-to)1230-1242
Number of pages13
JournalJACC: Cardiovascular Imaging
Issue number7
Publication statusPublished - Jul 2019


  • Anderson-Fabry disease
  • cardiovascular magnetic resonance
  • chaperone therapy
  • echocardiography
  • enzyme replacement therapy


Dive into the research topics of 'The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease'. Together they form a unique fingerprint.

Cite this